WASHINGTON (dpa-AFX) - Healthcare technology firm Medtronic plc (MDT) announced Wednesday the U.S. Food and Drug Administration (FDA) clearance for its new InPen app featuring missed meal dose ...

The Smart MDI system featuring the InPen and Simplera systems. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM ...

Medtronic plans to initiate a limited market release in the US, starting with existing standalone CGM and InPen customers ...